Thus, in patients affected by FAP, a screening colonoscopy with timely treatment of identified lesions has led to a 55% decrease in CRC as the first presenting sign leading to improvement in cumulative survival for the patients [13]. The gene discussed is FAP; the disease is colorectal carcinoma.